The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis
Other
OA: gold
CC0
⤵ 20 in-corpus citations
AI-generated summary
This study found that a diagnostic model combining hemoglobin, CA199, CA125, and HE4 achieved high sensitivity and specificity for diagnosing endometriosis compared to individual markers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: We aimed to analyze the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people, and establish a more efficient combined diagnostic model.
METHODS: We retrospectively analyzed the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people. Binary logistic regression analysis was used to establish a combined diagnostic model. We plotted the receiver operator characteristic (ROC) curve to analyze the diagnostic efficiency of different diagnostic indexes.
RESULTS: Compared with patients in the control group, patients in the endometriosis group had significantly lower eosinophil% (p = 0.045), neutrophil (p = 0.001), lymphocyte (p < 0.001), red blood cells (RBCs) (p < 0.001), and hemoglobin (HGB) (p < 0.001), and had significantly higher monocyte% (p = 0.008), monocyte-to-lymphocyte ratio (MLR) (p = 0.001), platelet-to-lymphocyte ratio (PLR) (p < 0.001), carbohydrate antigen (CA)-199 (p < 0.001), CA125 (p < 0.001), human epididymis protein (HE)-4 (p < 0.001), and the risk of ovarian malignancy algorithm (ROMA) (p < 0.001). The combined diagnostic model of HGB, CA199, CA125, and HE4 was established by binary logistic regression analysis. The ROC curve showed that the combined diagnostic model reached a sensitivity of 85.4%, a specificity of 78.83%, and an area under the curve of 0.900, which was significantly higher than that of the individual index in endometriosis diagnosis.
CONCLUSION: The combined diagnostic model of HGB, CA199, CA125, and HE4 may provide a new approach for the early non-invasive diagnosis of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- [A convenience sampling questionnaire survey of the current status of diagnosis and treatment of endometriosis in China in 2018] via openalex
- Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Comparison between Serum HE4 and CA125 as Tumor Markers in Premenopausal Women with Benign Pelvic Mass via openalex
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis via openalex
- Endometriosis and cancer: a systematic review and meta-analysis via openalex
- Endometriosis: correlation between histologic and visual findings at laparoscopy via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of elevated urinary enolase I levels in patients with endometriosis via openalex
- Inflammasome as a Key Pathogenic Mechanism in Endometriosis via openalex
- Multi-disciplinary centres/networks of excellence for endometriosis management and research: a proposal via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Recurrent endometriosis: a battle against an unknown enemy via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts via openalex
- Systemic Inflammatory Response Markers Associated with Infertility and Endometrioma or Uterine Leiomyoma in Endometriosis via openalex
- The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis via openalex
- The social and psychological impact of endometriosis on women's lives: a critical narrative review via openalex
- Urological and colorectal complications following surgery for rectovaginal endometriosis via openalex
- Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy via openalex
- What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis via openalex
- W2151934245 via openalex
- W2056664610 via openalex
- W2055527762 via openalex
- W4206485580 via openalex
Cited by (22)
- CA125 Outperforms HE4 and CA19-9 as a Serum Biomarker for Preoperative Diagnosis of Ovarian Endometriomas: A Retrospective Cohort Study 2026
- Endometriosis: Epidemiology, Risk Factors, Molecular Mechanisms, Diagnosis, and Management 2026
- Diagnostic value of non-invasive markers in the diagnosis of endometriosis (original study) 2026
- Prospective external validation and exploration of the "2021 AAGL endometriosis classification" 2025
- DESAFIOS NO DIAGNÓSTICO DA ENDOMETRIOSE: BARREIRAS E IMPACTOS NA SAÚDE FEMININA 2025
- Analysis of the Malignancy Risk of Endometriosis and Ovarian Cancer Related to Endometriosis-associated Ovarian Cancer: A Histopathological Review and Genetic Mutation 2025
- The Diagnostic Value of the CA125 and Ultrasound Combination for Endometriosis: A Retrospective Cohort Study 2025
- Identification and validation of a novel machine learning model for predicting severe pelvic endometriosis: A retrospective study 2025
- Enhancing endometrioma management: Diagnostic biomarkers and predictive outcomes in Ruptured vs. Non-Ruptured cases 2024
- The coagulation status in women of endometriosis with stage IV 2024
- Identification and Validation of a Novel Machine Learning Model for Predicting Severe Pelvic Endometriosis: A Retrospective Study 2024
- Immune сheckpoints in the context of external genital endometriosis 2024
- Comparison of the clinical efficacy of dienogest and drospirone/ethinyl estradiol in the treatment of ovarian endometriosis cysts 2024
- Additional file 1 of The coagulation status in women of endometriosis with stage IV 2024
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Serum HSF1 is upregulated in endometriosis patients and serves as a potential diagnostic biomarker 2023
- Diagnostic significance of neutrophil to lymphocyte ratio in endometriosis: a systematic review and meta-analysis 2023
- Predictive Value of Serum YKL-40, Interleukin-37, and Cancer Antigen 125 Panel in Noninvasive Staging of Endometriosis 2023
- Treatment of endometriosis with dienogest in combination with traditional Chinese medicine: A systematic review and meta-analysis 2022
- Research progress of CA125 in endometriosis: Teaching an old dog new tricks 2022
- Gynaecologic History During Adolescence to Predict Endometriosis Earlier 2022
- The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis 2021
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:32:03.440833+00:00
License: CC0
· commercial use OK